Danguole Altman
About Danguole Altman
Highly experienced entrepreneur, CEO and Director with an accomplished record of founding, leading, growing innovative life science and health care services companies. Deep knowledge of the health care industry developed through leading a broad range of health care companies and experience growing teams and attracting financing to propel growth. Specific management experience includes: • Diagnostics. Danguole currently serves as Chief Executive Officer of Cx Precision Medicine (CxPM), a company developing a suite of ground-breaking tools to improve the diagnosis and treatment of patients suffering from Alzheimer’s and Parkinson’s diseases. . Drug Development. Danguole served as co-Founder and CEO of Vapogenix, a clinical stage therapeutic company focused on non-opioid analgesics, based on IP licensed from MD Anderson Cancer Center, which she grew from pre-clinical to Phase 2 clinical trials. . Physician Practice Managment. CEO and Founder of a Private Equity backed women's health focused health care services company that grew to over $300 in practice revenues at its peak. • Managed Care Contracting. Danguole’s early career, both at McKinsey and afterwards, focused managed care contracting, reimbursement, and value-based pricing. Danguole led managed care contracting at a Kelsey-Seybold Clinic, improving the profitability of its capitated contracts through implementing value-based pricing and laying the foundation for its eventual designation as the nations’ first Accountable Health Care Plan. Danguole's board service has focused on serving two major non-profits: the Baltic-American Freedom Foundation (BAFF), a $30M endowment organization deepening ties between the US and Baltic States and and the Harvard Alumni Association, where she served on the Executive Committee.